As a result of increased innovation and modernization of therapeutic treatments, the diabetes market has matured significantly during the last 20 years. Because the condition is so common, and patient numbers are likely to continue to rise in the near future, drug developers have found it to be a lucrative market. As a result, according to Global Data, a prominent data and analytics organization, the global market size, as measured by pharmaceutical sales, has expanded sixfold since 2000. The global market for diabetes monitoring devices is expected to expand at a compound annual growth rate (CAGR) of 6.5 percent from $19.7 billion in 2020 to $27.0 billion in 2025.